HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Ruzicka Selected Research

Tacrolimus (Prograf)

12/2009Topical treatment of perianal eczema with tacrolimus 0.1%.
12/2008Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
9/2008A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
7/2008Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
6/2008Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
11/2006Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
4/2006[Multifocal facial eosinophilic granuloma: successful treatment with topical tacrolimus].
10/2005[Perioral dermatitis following treatment with tacrolimus].
4/2005[Topical treatment of subacute-cutaneous lupus erythematosus with tacrolimus].
12/2004The role of topical calcineurin inhibitors in atopic dermatitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Ruzicka Research Topics

Disease

16Atopic Dermatitis (Atopic Eczema)
02/2016 - 05/2000
14Eczema
12/2015 - 03/2002
12Psoriasis (Pustulosis Palmaris et Plantaris)
05/2012 - 05/2000
11Rosacea (Acne Rosacea)
06/2017 - 01/2008
11Hypersensitivity (Allergy)
12/2015 - 02/2000
10Neoplasms (Cancer)
08/2017 - 06/2001
8Skin Diseases (Skin Disease)
07/2013 - 05/2000
8Inflammation (Inflammations)
01/2013 - 05/2000
6Actinic Keratosis
01/2019 - 06/2001
6Infections
07/2014 - 10/2001
5Necrosis
08/2010 - 05/2000
4Bullous Pemphigoid (Pemphigoid)
11/2019 - 08/2001
4Melanoma (Melanoma, Malignant)
08/2017 - 02/2001
4Erythema
12/2016 - 02/2000
4Pruritus (Itching)
02/2016 - 02/2004
4Basal Cell Carcinoma (Rodent Ulcer)
07/2011 - 06/2001
4Cutaneous Lupus Erythematosus
04/2005 - 02/2000
3Contact Dermatitis (Eczema, Contact)
12/2015 - 04/2003
3Cicatrix (Scar)
10/2015 - 08/2000
3Disease Progression
12/2008 - 02/2003
3Acute Disease
12/2008 - 06/2008
3Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
11/2004 - 08/2001
3Pemphigus (Pemphigus Vulgaris)
04/2004 - 08/2001
2Hidradenitis Suppurativa
06/2021 - 01/2019
2Exanthema (Rash)
06/2017 - 01/2013
2Acne Vulgaris
11/2016 - 10/2015
2Skin Neoplasms (Skin Cancer)
11/2015 - 05/2008
2Granuloma
08/2015 - 04/2005
2Mycosis Fungoides
04/2015 - 12/2009
2Warts (Wart)
03/2015 - 12/2013
2Papillomavirus Infections
12/2013 - 10/2013
2Paraproteinemias (Monoclonal Gammopathy)
01/2013 - 02/2006
2Nevus (Nevi)
07/2011 - 04/2005
2Ulcer
07/2010 - 07/2001
2Acantholysis
07/2010 - 04/2004
2Varicose Ulcer (Ulcer, Venous)
07/2010 - 02/2009
2Discoid Lupus Erythematosus
12/2009 - 01/2000
2Pyoderma Gangrenosum
11/2009 - 02/2000
2Cutaneous Leishmaniasis
08/2007 - 04/2004
2Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
11/2006 - 06/2005
2Porphyria Cutanea Tarda
03/2006 - 12/2003
2Porphyrias (Porphyria)
03/2006 - 12/2003
2Leukemia
02/2006 - 04/2003
2Hepatitis B
02/2006 - 12/2003
2Hyperpigmentation
03/2002 - 08/2000
2Leg Ulcer
07/2001 - 01/2000

Drug/Important Bio-Agent (IBA)

17Tacrolimus (Prograf)FDA LinkGeneric
12/2009 - 01/2000
10AlitretinoinFDA Link
04/2015 - 04/2008
10Ointments (Pastes)IBA
12/2009 - 05/2000
6Ivermectin (Mectizan)FDA Link
06/2017 - 04/2015
6Pharmaceutical PreparationsIBA
07/2009 - 05/2000
5CytokinesIBA
02/2016 - 05/2000
5Proteins (Proteins, Gene)FDA Link
04/2015 - 10/2001
5Adrenal Cortex Hormones (Corticosteroids)IBA
04/2008 - 12/2004
4Irritants (Vesicants)IBA
12/2015 - 10/2009
41-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2015 - 06/2001
4EnzymesIBA
04/2015 - 03/2002
4Calcineurin InhibitorsIBA
12/2009 - 12/2004
3Metronidazole (Metric)FDA LinkGeneric
12/2016 - 04/2015
3Anti-Bacterial Agents (Antibiotics)IBA
12/2016 - 07/2014
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2016 - 11/2009
3NickelIBA
12/2015 - 11/2004
3Antimicrobial PeptidesIBA
03/2012 - 01/2008
3CollagenIBA
01/2012 - 08/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2009 - 10/2001
3Anti-Inflammatory Agents (Anti-Inflammatories)IBA
12/2008 - 06/2008
3SolutionsIBA
09/2008 - 07/2001
3Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2004 - 08/2001
2Isotretinoin (Accutane)FDA LinkGeneric
12/2016 - 09/2015
2Hydrocortisone (Cortisol)FDA LinkGeneric
02/2016 - 12/2004
2Biomarkers (Surrogate Marker)IBA
10/2015 - 09/2012
2Peptide Hydrolases (Proteases)FDA Link
04/2015 - 02/2006
2Filaggrin ProteinsIBA
04/2015 - 10/2009
2InflammasomesIBA
10/2013 - 11/2012
2Infliximab (Remicade)FDA Link
08/2010 - 02/2004
2Peptides (Polypeptides)IBA
01/2009 - 01/2008
2CathelicidinsIBA
01/2009 - 01/2008
2AntigensIBA
02/2006 - 03/2001
2AutoantibodiesIBA
06/2005 - 04/2004
2EmollientsIBA
12/2004 - 03/2002
2SteroidsIBA
12/2004 - 08/2001
2Imiquimod (Aldara)FDA LinkGeneric
12/2004 - 12/2002
2Immunologic Factors (Immunomodulators)IBA
04/2004 - 10/2001
2PorphyrinsIBA
12/2001 - 06/2001
2Aminolevulinic Acid (Levulan)FDA Link
09/2001 - 06/2001
2AntibodiesIBA
11/2000 - 04/2000
2Antimalarials (Antimalarial Agents)IBA
08/2000 - 02/2000
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2021
1PyrinIBA
01/2019
1Immunoglobulin G (IgG)IBA
04/2018

Therapy/Procedure

38Therapeutics
08/2017 - 02/2000
8Photochemotherapy (Photodynamic Therapy)
11/2015 - 06/2001
3Lasers (Laser)
11/2019 - 01/2000
2Aftercare (After-Treatment)
08/2017 - 07/2015
2Solid-State Lasers
10/2015 - 08/2000
2Injections
08/2015 - 01/2012
2Climatotherapy
05/2012 - 08/2011
2Radiotherapy
07/2011 - 10/2005
2Immunotherapy
02/2006 - 10/2001
1Cryosurgery
01/2019